World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
67
Citations
14964
World Ranking
2681
National Ranking
1283

Ted M. Ross publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Ted M. Ross sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 327 publications — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Ted M. Ross D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Ted M. Ross sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 67 D-Index — 47th percentile

47% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Ted M. Ross is affiliated with the University of Georgia in the United States. Their research primarily focuses on medicine and immunology and microbiology, with a substantial number of publications in these fields.

The scientist's work includes significant contributions to epidemiology, immunology, infectious diseases, molecular biology, and radiology, nuclear medicine, and imaging. Their main topics of study involve influenza virus research, respiratory viral infections, SARS-CoV-2 and COVID-19 research, immune response and inflammation, monoclonal and polyclonal antibodies, vaccines and immunoinformatics approaches, and immune cell function and interaction.

Frequent publication venues for Ted M. Ross include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Vaccine
  • Journal of Virology
  • Vaccines
  • Frontiers in Immunology

Frequent co-authors in their research are:

  • Michael A. Carlock
  • Giuseppe A. Sautto
  • Eric M. Bachelder
  • Kristy M. Ainslie
  • James D. Allen

Selected recent papers authored or co-authored by Ted M. Ross include:

  • Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection (2021, Cell)
  • Extremely potent human monoclonal antibodies from COVID-19 convalescent patients (2021, Cell)
  • De novo design of potent and resilient hACE2 decoys to neutralize SARS-CoV-2 (2020, Science)
  • Better Epitope Discovery, Precision Immune Engineering, and Accelerated Vaccine Design Using Immunoinformatics Tools (2020, Frontiers in Immunology)
  • Development and deployment of COVID-19 vaccines for those most vulnerable (2021, Science Translational Medicine)

Best Publications

  • Critical Role of IL-17RA in Immunopathology of Influenza Infection

    Christopher R. Crowe;Kong Chen;Derek A. Pociask;John F. Alcorn

  • Inhibition of HIV-1 progeny virion release by cell-surface CD4 is relieved by expression of the viral Nef protein.

    Ted M. Ross;Alp E. Oran;Bryan R. Cullen

  • Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection.

    Emma S. Winkler;Pavlo Gilchuk;Jinsheng Yu;Adam L. Bailey

  • Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.

    Rick A. Bright;Donald M. Carter;Shannon Daniluk;Franklin R. Toapanta

  • C3d enhancement of antibodies to hemagglutinin accelerates protection against influenza virus challenge.

    Ted M. Ross;Yan Xu;Rick A. Bright;Harriet L. Robinson

  • Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccination

    Jiwon Lee;Daniel R. Boutz;Veronika Chromikova;M. Gordon Joyce

  • Impaired immune responses in the lungs of aged mice following influenza infection

    Franklin R Toapanta;Franklin R Toapanta;Ted M Ross

  • Cross-Clade Protective Immune Responses to Influenza Viruses with H5N1 HA and NA Elicited by an Influenza Virus-Like Particle

    Rick A. Bright;Donald M. Carter;Corey J. Crevar;Franklin R. Toapanta

  • Identification of Hemagglutinin Residues Responsible for H3N2 Antigenic Drift during the 2014-2015 Influenza Season.

    Benjamin S. Chambers;Kaela Parkhouse;Ted M. Ross;Kevin Alby

  • A computationally optimized broadly reactive antigen (COBRA) based H5N1 VLP vaccine elicits broadly reactive antibodies in mice and ferrets.

    Brendan M. Giles;Ted M. Ross

  • Dengue virus and the host innate immune response

    Naoko Uno;Ted M. Ross

  • Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013–2014 influenza season

    Susanne L. Linderman;Benjamin S. Chambers;Seth J. Zost;Kaela Parkhouse

  • Design and Characterization of a Computationally Optimized Broadly Reactive Hemagglutinin Vaccine for H1N1 Influenza Viruses

    Donald M. Carter;Christopher A. Darby;Bradford C. Lefoley;Corey J. Crevar

  • Towards a universal influenza vaccine: different approaches for one goal

    Giuseppe A. Sautto;Greg A. Kirchenbaum;Ted M. Ross

  • Immune history shapes specificity of pandemic H1N1 influenza antibody responses

    Yang Li;Jaclyn L. Myers;David L. Bostick;Colleen B. Sullivan

  • Extremely potent human monoclonal antibodies from COVID-19 convalescent patients.

    Emanuele Andreano;Emanuele Nicastri;Ida Paciello;Piero Pileri

  • H3N2 influenza viruses in humans: Viral mechanisms, evolution, and evaluation.

    James D. Allen;Ted M. Ross

  • H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses.

    Kutubuddin Mahmood;Rick A. Bright;Nutan Mytle;Donald M. Carter

  • Intranasal Antibody Gene Transfer in Mice and Ferrets Elicits Broad Protection Against Pandemic Influenza

    Maria P. Limberis;Virginie S. Adam;Gary Wong;Gary Wong;Jason Gren;Jason Gren

  • De novo design of potent and resilient hACE2 decoys to neutralize SARS-CoV-2

    Thomas W. Linsky;Renan Vergara;Nuria Codina;Jorgen W. Nelson

  • Enhancement of antibodies to the human immunodeficiency virus type 1 envelope by using the molecular adjuvant C3d.

    Thomas D. Green;David C. Montefiori;Ted M. Ross

Frequent Co-Authors

Clayton A. Wiley
Clayton A. Wiley University of Pittsburgh
Elodie Ghedin
Elodie Ghedin National Institutes of Health
Anne S. De Groot
Anne S. De Groot University of Georgia
Richard K. Zimmerman
Richard K. Zimmerman University of Pittsburgh
Scott E. Hensley
Scott E. Hensley University of Pennsylvania
Surender Khurana
Surender Khurana US Food and Drug Administration
David E. Swayne
David E. Swayne United States Department of Agriculture
Hana Golding
Hana Golding US Food and Drug Administration
Michael S. Diamond
Michael S. Diamond Washington University in St. Louis
Bin Zhang
Bin Zhang Icahn School of Medicine at Mount Sinai

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to various specialized healthcare careers, including advanced nursing roles that intersect with immune system-related health. For those interested in mental health and immunology’s role in psychiatric conditions, exploring the cheapest psychiatric nurse practitioner programs can be a cost-effective way to enter this impactful field.

Many professionals pursue a Doctorate in Nursing Practice to deepen their expertise, and understanding the doctorate in nursing salary can help set realistic financial goals after graduation. These programs often prepare students for specialized roles that deal with immune-related diseases and patient care.

Transitioning from a Family Nurse Practitioner to more intensive roles, such as acute care, is possible through targeted education. The guide on acute care nurse practitioner programs outlines the steps needed to make this shift, which can complement immunology knowledge by focusing on patients with critical immune system challenges.

For those looking to accelerate their career timeline, accelerated NP programs offer faster routes to nurse practitioner credentials, allowing quicker application of immunological expertise in clinical settings. These pathways illustrate the intersection of immunology with advanced nursing education and career development.

Best Scientists Citing Ted M. Ross

Trending Scientists

Recently Published Articles